A feedback regulatory pathway between LDL and alpha 1 proteinase inhibitor in chronic inflammation and infection

Discovery Medicine

Volumn 16, Issue 89, 2013, Pages 201-218

  Bristow, Cynthia L ^a,b   Modarresi, Rozbeh ^a,b   Babayeva, Mariya A ^a,b   LaBrunda, Michelle ^a,c   Mukhtarzad, Roya ^a,d   Franklin, Aaron ^a,e   Reeves, Rudy E R ^a,f   Trucy, Maylis ^a   Long, Allegra ^a,g   Mullen, Michael P ^h   Cortes, Jose ⁱ   Winston, Ronald ^a  

^a Inst for Hum Genet and Biochem   (Switzerland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Holmes Regional Medical Center   (United States)

^d Infectious Diseases Medicine Kingsbrook Jewish Medical Center   (Switzerland)

^e MEDICAL COLLEGE OF OHIO   (United States)

^f LEWIS AND CLARK COLLEGE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CLUSTERIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN LIKE 2; LOW DENSITY LIPOPROTEIN; PEPTIDES AND PROTEINS; SCAVENGER RECEPTOR B; SYNAPTOTAGMIN III; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL VIABILITY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DNA MICROARRAY; ENDOCYTOSIS; EPIFLUORESCENCE MICROSCOPY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPODYSTROPHY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; VIRUS ENTRY;

ADULT; ALPHA 1-ANTITRYPSIN; CELL LINE; CELLS, CULTURED; ENDOCYTOSIS; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; SERINE PROTEINASE INHIBITORS;

EID: 84889597424     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Arthos J, Cicala C, Steenbeke RD, Chun T-W, Dela Cruz C, Hanback DB, Khazanie P, Nam D, Schuck P, Selig SM, Van Ryk D, Chaikin MA, Fauci AS. Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein. J Biol Chem 277:11456-11464, 2002.
2. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D, Xiao Z, Veenstra TD, Conrad TP, Lempicki RA, McLaughlin S, Pascuccio M, Gopaul R, McNally J, Cruz CC, Censoplano N, Chung E, Reitano KN, Kottilil S, Goode DJ, et al. HIV-1 envelope protein binds to and signals through integrin [alpha]4[beta]7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9(3):301-309, 2008.
3. Barbouche R, Lortat-Jacob H, Jones IM, Fenouillet E. Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env. Mol Pharmacol 67(4):1111-1118, 2005.
4. Barbouche R, Miquelis R, Jones IM, Fenouillet E. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 278(5):3131-3136, 2003.
5. Biswas P, Mengozzi M, Mantelli B, Delfanti F, Brambilla A, Vicenzi E, Poli G. 1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-κB-independent enhancement of viral replication. J Virol 72(10):8380-8383, 1998.
6. Borrell-Pagès M, Romero JC, Juan-Babot O, Badimon L. Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages. Eur Heart J 32(22):2841-2850, 2011.
7. + lymphocyte levels and is rate limiting in HIV-1 disease. PLoS One 7:e31383, 2012.
8. + lymphocytes to normal values in HIV-1 patients. In: Soluble Factors Mediating Innate Immune Responses to HIV Infection. Alfano M (ed.). Bentham Science Publishers, Oak Park, Illinois, USA, 2010.
9. Bristow CL, di Meo F, Arnold RR. Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: Application to insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 89:247-259, 1998.
10. Bristow CL, Fiscus SA, Flood PM, Arnold RR. Inhibition of HIV-1 by modification of a host membrane protease. Int Immunol 7:239-249, 1995.
11. Bristow CL, Flood PM. T cell antigen receptor immune complexes demonstrating biologic and proteolytic activity. Int Immunol 5:79-88, 1993.
12. Bristow CL, Mercatante DR, Kole R. HIV-1 preferentially binds receptors co-patched with cell surface elastase. Blood 102:4479-4486, 2003.
13. Bristow CL, Patel H, Arnold RR. Self antigen prognostic for human immunodeficiency virus disease progression. Clin Diagn Lab Immunol 8:937-942, 2001.
14. Bristow CL, Wolkowicz R, Trucy M, Franklin A, Di Meo F, Kozlowski MT, Winston R, Arnold RR. NF-κB signaling, elastase localization, and phagocytosis differ in HIV-1 permissive and nonpermissive U937 clones. J Immunol 180(1):492-499, 2008.
15. Bryan C, Beard KS, Pott GB, Rahkola J, Gardner EM, Jano EN, Shapiro L. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations. Clin Invest Med 33(6):E384-E389, 2010.
16. Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. PNAS 105(25):8718-8723, 2008.
17. Cao C, Lawrence DA, Li Y, Von Amin CA, Herz J, Su EJ, Makarova A, Hyman BT, Strickland DK, Zhang L. Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J 25:1860-1870, 2006.
18. Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 82(5):1212-1220, 2007.
19. Frank I, Piatak MJ, Stoessel H, Romani N, Bonnyay D, Lifson JD, Pope M. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J Virol 76:2936-2951, 2002.
20. Hansson G. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 7:328-331, 2009.
21. He X, Kappes DJ. CD4/CD8 lineage commitment:light at the end of the tunnel? Curr Opin Immunol 18:135-142, 2006.
22. Hubner W, McNerney G, Chen P, Dale BM, Gordon RE, Chuang FYS, Li S-D, Asmuth DM, Huser T, Chen BK. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323:1743-1747, 2009.
23. James HL, Cohen AB. Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin. J Clin Invest 62:1344-1353, 1978.
24. Janciauskiene S, Moraga F, Lindgren S. C-terminal fragment of [alpha]1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor. Atherosclerosis 158(1):41-51, 2001.
25. Kim TW, Febbraio M, Robinet P, DuGar B, Greene D, Cerny A, Latz E, Gilmour R, Staschke K, Chisolm G, Fox PL, DiCorleto PE, Smith JD, Li X. The critical role of IL-1 receptor-associated kinase 4-mediated NF-κB activation in modified low-density lipoprotein-induced inflammatory gene expression and atherosclerosis. J Immunol 186(5):2871-2880, 2011.
26. Kounnas MZ, Church FC, Argraves WS, Strickland DK. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. J Biol Chem 271:6523-6529, 1996.
27. Kramer HB, Lavender KM, Qin L, Stacey AR, Liu MKP, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ, Borrow P, Kessler BM. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog 6:e1000893, 2010.
28. Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Meth 3(5):361-368, 2006.
29. Mashiba S, Wada Y, Takeya M, Sugiyama A, Hamakubo T, Nakamura A, Noguchi N, Niki E, Izumi A, Kobayashi M, Uchida K, Kodama T. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. Arterioscler Thromb Vasc Biol 21:1801-1808, 2001.
30. Matthews TJ, Weinhold KJ, Lyerly HK, Langlois AJ, Wigzell H, Bolognesi DP. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci USA 84:5424-5428, 1987.
31. Mehlhop E, Villamide LA, Frank I, Gettie A, Santisteban C, Messmer D, Ignatius R, Lifson JD, Pope M. Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J Immunol Methods 260:219-234, 2002.
32. Modarresi R, Xiang Z, Yin M, Laurence J. WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss. Am J Pathol 174(1):123-135, 2009.
33. Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82-92, 1994.
34. Moriuchi H, Moriuchi M, Fauci AS. Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J Virol 74(15):6849-6855, 2000.
35. Munch J, Standker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pohlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, KirchhoffF. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 129(2):263-275, 2007.
36. Owen FL, Finnegan A, Gates ER, Gottlieb PD. A mature T lymphocyte subpopulation marker closely linked to the Ig-1 allotype locus. Eur J Immunol 9:948, 1979.
37. Rato S, Maia S, Brito PM, Resende L, Pereira CF, Moita C, Freitas RP, Moniz-Pereira J, Hacohen N, Moita LF, Goncalves J. Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cell. PLoS One 5(2):e9276, 2010.
38. Rossio JL, Esser MT, Suryanarayana K, Schneider DK, Bess JW Jr, Vasquez GM, Wiltrout TA, Chertova E, Grimes MK, Sattentau Q, Arthur LO, Henderson LE, Lifson JD. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 72:7992-8001, 1998.
39. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. PNAS 91(10):4559-4563, 1994.
40. Shapiro L, Pott GB, Ralston AH. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J 15:115-122, 2001.
41. Spina CA, Guatelli JC, Richman DD. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 69:2977-2988, 1995.
42. Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, Esposito R, Guaraldi G. Detectable HIV viral load is associated with metabolic syndrome. JAIDS 52(4):459-464, 2009.
43. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 64:2421-2425, 1990a.
44. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 9:1551-1560, 1990b.
45. Tyagi SC. Reversible inhibition of neutrophil elastase by thiol-modified alpha-1 protease inhibitor. J Biol Chem 266:5279-5285, 1991.
46. Veniant M, Zlot CH, Walzem RL, Pierotti V, Driscoll R, Dichek D, Herz J, Young SG. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. J Clin Invest 102(8):1559-1568, 1998.
47. Vidricaire G, Tremblay MJ. A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J Mol Biol 368:1267-1283, 2007.
48. Wen W, Chen S, Cao Y, Zhu Y, Yamamoto Y. HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells. Virus Res 113:26-35, 2005.
49. Winkler IG, Hendy J, Coughlin P, Horvath A, Levesque JP. Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med 201(7):1077-1088, 2005.
50. Wu Y, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293:1503-1506, 2001.
51. Xie QM, Shao JS, Alpers DH. Rat intestinal alpha1-antitrypsin secretion is regulated by triacylglycerol feeding. Am J Physiol 276(6):G1452-G1460, 1999.